Literature DB >> 8957360

Does resection of adrenal metastases from non-small cell lung cancer improve survival?

J D Luketich1, M E Burt.   

Abstract

BACKGROUND: Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis, which is minimally affected by chemotherapy. Solitary brain metastases from NSCLC have been resected with 5-year survivals of 10% to 30%. The objective of this study was to determine if resection of isolated adrenal metastases improves survival.
METHODS: Isolated adrenal metastases were found in 14 patients with NSCLC. Eight patients had resection after cis-platinum-based chemotherapy, and 6 received chemotherapy alone.
RESULTS: Median survival in the surgical group was significantly greater than that in the chemotherapy group (31 versus 8.5 months; p = 0.03). All patients in the chemotherapy group were dead by 22 months. Three-year actuarial survival in the surgical group was 38%. No difference in locoregional stage, size of adrenal metastases, patient age, or performance status was present between the two groups.
CONCLUSIONS: Long-term disease-free survival is possible after resection of isolated adrenal metastases from NSCLC. Resection of isolated adrenal metastases should be considered if the primary NSCLC is resectable.

Entities:  

Mesh:

Year:  1996        PMID: 8957360     DOI: 10.1016/s0003-4975(96)00611-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  49 in total

1.  Trends in adrenal surgery: institutional review of 528 consecutive adrenalectomies.

Authors:  Anja Lachenmayer; Kenko Cupisti; Achim Wolf; Andreas Raffel; Matthias Schott; Holger S Willenberg; Claus F Eisenberger; Wolfram T Knoefel
Journal:  Langenbecks Arch Surg       Date:  2012-06-22       Impact factor: 3.445

2.  Laparoscopic adrenalectomy for solitary metachronous adrenal metastasis from lung cancer: report of a case.

Authors:  Y Tsuji; M Yasuhuku; T Haryu; Y Watanabe; K Ataka; M Okada
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Surgical resection of metastases to the adrenal gland: a single center experience.

Authors:  I Hornstein; C Schwarz; S Ebbing; M Hoppe-Lotichius; G Otto; H Lang; T J Musholt
Journal:  Langenbecks Arch Surg       Date:  2015-03-01       Impact factor: 3.445

4.  Recurrent maxillary sinus cancer with only adrenal metastasis.

Authors:  Hye Jung Chang; Joon-Young Hur; Kyu Yeoun Won; Boksoon Chang; Ha Yeon Lee
Journal:  Mol Clin Oncol       Date:  2017-09-20

5.  Adrenal metastectomy is safe in selected patients.

Authors:  Minerva Angelica Romero Arenas; Dawen Sui; Elizabeth G Grubbs; Jeffrey E Lee; Nancy D Perrier
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

Review 6.  The role of radiation therapy in the treatment of metastatic cancer.

Authors:  Baldassarre Stea; Tijana Skrepnik; Charles C Hsu; Roy Abendroth
Journal:  Clin Exp Metastasis       Date:  2018-07-30       Impact factor: 5.150

7.  A novel paradigm in the treatment of oligometastatic non-small cell lung cancer.

Authors:  Salma K Jabbour; Parima Daroui; Dirk Moore; Edward Licitra; Molly Gabel; Joseph Aisner
Journal:  J Thorac Dis       Date:  2011-03       Impact factor: 2.895

8.  Survival following laparoscopic adrenalectomy for solitary metastasis of lung cancer.

Authors:  Senol Tonyali; Hakan Bahadir Haberal; Sertac Yazici; Mustafa Erman; Zafer Volkan Kaynaroglu; Cenk Yucel Bilen
Journal:  Int Urol Nephrol       Date:  2016-07-14       Impact factor: 2.370

Review 9.  Adrenalectomy for isolated metastasis from operable non-small-cell lung cancer.

Authors:  Priya Sastry; Adam Tocock; Aman S Coonar
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-18

10.  Adrenalectomy may increase survival of patients with adrenal metastases.

Authors:  Qing-You Zheng; Guo-Hui Zhang; Yong Zhang; Ying-Liu Guo
Journal:  Oncol Lett       Date:  2012-02-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.